PHARMAGEDDON
USA
- A NEW EVENT FOR PHARMA
- APRIL 23-24, 2025
- PHILADELPHIA, USA
Working in our industry should be something to be proud of: to save and improve human life is one of the most noble causes to dedicate a life to. But our current model is stifling our ability to deliver.
We can do better. Join the movement.
Pharmageddon USA is a 2-day innovation experience designed to reframe your thinking from what pharma is to what it could be. We’ve thrown out drawn-out vendor presentations and predictable press readings and replaced them with Ted-talk style case studies and provocative panels.
Rather than sitting on your hands, at Pharmageddon you’ll get them dirty as we help you to envision then create a new and improved future through our unique solve sessions. It’s the event of the year for industry innovators, and you don’t have to take our word for it:
“The focus was on innovation, digital and then new value proposition for patients and healthcare - critical elements in challenging the pharma status quo and encouraging industry disruption to create a more sustainable, greater future.”
Stefan König
CEO, Merz Therapeutics
“A fantastic opportunity to both share our insights and learn from other dedicated pharma professionals who share the same commitment to transforming the pharmaceutical industry for the benefit of patients.”
Jennifer Villagarcia
Global Medical Engagement Strategy and Content Lead, Vaccines, Sanofi
“I'm grateful for the opportunity to share insights and engage with industry leaders on how to beat the treadmill. We should focus on delivering business value and not only transforming business for the sake of following a trend.”
Tiana Homsani
Global Head of Marketing Excellence, Abbott
“The meeting putting a fire under the pharmaceutical industry... Left me with a deeper sense of why I work in medical affairs in pharma.”
Rob Hastings
Medical Affairs Director, Novartis UK
“Lots of thought-provoking discussions on innovation and patient engagement across the industry, and a deep dive into rethinking patient-pharma relationships.”
Alex Artyomenko
Global Patient Affairs Director, Rare Diseases, Ipsen
“Bringing together the Pharma industry and patients to co-create and redesign with new lenses a new way to collaborate in the future is a great challenge that Paul Simms and the Impatient Health team took on.
As patient advocates, we were given the opportunity to open the two day event. And we did. We challenged the industry and shared our ideas to really work with the patient.”
Teresa Ferreiro
Founder and CEO, Soul Reconnect
“I came back to work after Pharmageddon energised, inspired and full of hope about our ability to embrace the change needed to contribute better to patient health. We were all there to drive or to be part of the change.”
Claire Chartier
Global Medical Excellence Director, Grünenthal
Email Lucy Osborne at [email protected]
Thanks for being keen to join us in New York.
Our intention is to have one non-affiliated ‘patient’ for each team taking part.
If you are interested in being one of these, please write to Lucy on [email protected].
We also have a limited number of spaces for HCPs, media and others. Please write to Paul on [email protected] if eager to take part.
